Short Description
Peginterferon Alfa-2b 100mcg is an injectable medicine belonging to the pegylated interferon class, used mainly in the treatment of chronic hepatitis C, often alongside other antiviral medicines. It works by supporting the body’s immune response against the virus and is administered under medical supervision as part of a structured treatment course.
What Is Peginterferon Alfa-2b 100mcg?
Peginterferon Alfa-2b 100mcg contains peginterferon alfa-2b, a modified (pegylated) form of interferon alfa-2b, a protein naturally produced by the body as part of its immune defences. The pegylation process allows the medicine to stay active in the body for longer, generally supporting a once-weekly injection schedule rather than more frequent dosing.
It belongs to a group of medicines known as interferons, which help regulate the immune system’s response to viral infection. Peginterferon Alfa-2b is typically prescribed as part of a defined treatment course for chronic hepatitis C, sometimes in combination with other antiviral medicines, with the exact regimen and duration decided by the prescribing doctor.
Uses
Peginterferon Alfa-2b 100mcg may be prescribed to:
Treat chronic hepatitis C infection, often in combination with other antiviral medicines
Support antiviral treatment in adults who have not previously been treated with interferon-based therapy, where appropriate
The appropriate use, dose, and duration of treatment with Peginterferon Alfa-2b should be determined by a healthcare professional based on individual diagnosis and response to therapy.
How Does Peginterferon Alfa-2b Work?
Peginterferon Alfa-2b works by mimicking the activity of interferon, a protein the body produces naturally to help fight viral infections. It helps stimulate the immune system’s antiviral response, which can assist the body in reducing viral activity over the course of treatment.
The “peg” portion of the medicine (polyethylene glycol) is attached to the interferon molecule to slow its clearance from the body, allowing for less frequent injections while maintaining a more consistent level of activity. Response to treatment is generally assessed through blood tests at intervals determined by the prescribing doctor, and the full effect develops gradually over the treatment course rather than immediately.
How to Take Peginterferon Alfa-2b
Take Peginterferon Alfa-2b exactly as prescribed by your healthcare professional.
Usually given as a subcutaneous (under-the-skin) injection once weekly
Injected on the same day and, where possible, around the same time each week
May be self-administered or given by a healthcare professional, depending on training and local practice
The injection site is usually rotated (such as between the abdomen and thigh) to reduce irritation
Do not stop or change your treatment schedule without speaking to your doctor, as inconsistent dosing can affect treatment outcomes
If a dose is missed, contact your doctor or pharmacist for guidance rather than adjusting the schedule independently, as timing depends on the overall treatment plan.
Important Safety Information
Before starting Peginterferon Alfa-2b, tell your doctor or pharmacist about your full medical history and all medicines, supplements, and herbal products you currently use.
Caution or closer monitoring may be needed if you have:
A history of depression, anxiety, or other mental health conditions
Autoimmune disorders
Heart problems, including irregular heartbeat or a history of heart attack
Liver disease other than the condition being treated
Thyroid disorders
Blood disorders, including low blood cell or platelet counts
Eye conditions, particularly diabetic or hypertensive retinopathy
Peginterferon Alfa-2b can interact with other medicines affecting the immune system, bone marrow, or liver function, including certain antiviral and chemotherapy medicines. Because treatment often involves combination therapy, it’s especially important to check possible interactions with a doctor or pharmacist before starting or combining treatments.
Pregnancy & Breastfeeding
Peginterferon Alfa-2b is generally not recommended during pregnancy unless considered clearly necessary by a treating doctor, and additional caution applies when it is used together with other antiviral medicines that may carry separate pregnancy-related restrictions. Recommendations may vary depending on the specific combination therapy prescribed.
It is not fully established whether Peginterferon Alfa-2b passes into breast milk, so breastfeeding during treatment is generally only considered after discussion with a healthcare professional. Speak with your doctor or pharmacist if you are pregnant, planning a pregnancy, or breastfeeding.
Side Effects
Like all medicines, Peginterferon Alfa-2b can cause side effects, although not everyone experiences them.
Common side effects include:
Flu-like symptoms (fever, chills, muscle or joint aches)
Fatigue or weakness
Headache
Nausea
Injection site reactions (redness, swelling, or irritation)
Low mood, irritability, or difficulty sleeping
Seek prompt medical attention if you experience thoughts of self-harm or suicide, severe or worsening depression, signs of infection, unusual bleeding or bruising, chest pain or an irregular heartbeat, vision changes, or signs of a serious allergic reaction such as facial swelling or difficulty breathing.
This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.
Storage
Store Peginterferon Alfa-2b according to the instructions shown on the original product packaging.
Keep in the original packaging, protected from light
Unmixed vials or pens are generally kept refrigerated; always check the specific storage condition on your product’s packaging
Do not freeze
Keep out of reach and sight of children
Do not use after the expiry date shown on the packaging